Page 3 - புற்றுநோயியல் பார்மா இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from புற்றுநோயியல் பார்மா இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In புற்றுநோயியல் பார்மா இன்க் Today - Breaking & Trending Today

Oncology Pharma and Ribera Solutions Release White Paper Regarding Patient Engagement and Retention Platform

Oncology Pharma and Ribera Solutions Release White Paper Regarding Patient Engagement and Retention Platform
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.

United States , San Francisco , Ribera Solutions , Oncology Pharma Inc , Trial Support Community , Patient Concierge Service , Health Literacy , Oncology Pharma , White Paper , Easy To Use User Interface , Advisory Board , Sansome Street , United States Wire Group , ஒன்றுபட்டது மாநிலங்களில் , சான் பிரான்சிஸ்கோ , ரிபேரா தீர்வுகள் , புற்றுநோயியல் பார்மா இன்க் , நோயாளி வரவேற்பு சேவை , ஆரோக்கியம் கல்வியறிவு , புற்றுநோயியல் பார்மா , வெள்ளை காகிதம் , ஒன்றுபட்டது மாநிலங்களில் கம்பி குழு ,

Oncology Pharma Inc.: Oncology Pharma, Inc. Has Submitted Its Initial Application to List the Company on the Capital Markets Tier of the NASDAQ Exchange

(0)
SAN FRANCISCO, CA / ACCESSWIRE / May 12, 2021 /
Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the Company ) has submitted its initial application to the NASDAQ to begin the process of moving the listing from the Pink Sheets to the Capital Markets Tier of the NASDAQ Exchange. The Company, its Board, advisors and management team are going to devote resources to accomplish this as swiftly as possible. We are delighted to have submitted the initial application and will work through the process utilizing all resources to our disposal.
ABOUT ONCOLOGY PHARMA, INC.
ONCOLOGY PHARMA, INC. (OTC PINK:ONPH) (the Company ) is currently engaging in research and development of therapeutics for oncology and prides itself for having a world-class Advisory Board that keeps the Company in the forefront of developing technologies in cancer research, biotechnology, and healthcare. ....

San Francisco , United States , Kostenloser Wertpapierhandel , Oncology Pharma Inc , Oncology Pharma , Pink Sheets , Capital Markets Tier , Advisory Board , Sansome Street , சான் பிரான்சிஸ்கோ , ஒன்றுபட்டது மாநிலங்களில் , புற்றுநோயியல் பார்மா இன்க் , புற்றுநோயியல் பார்மா , இளஞ்சிவப்பு தாள்கள் ,

Oncology Pharma, Inc. Has Submitted Its Initial Application to List the Company on the Capital Markets Tier of the NASDAQ Exchange

Oncology Pharma, Inc. Has Submitted Its Initial Application to List the Company on the Capital Markets Tier of the NASDAQ Exchange
ACCESSWIRE
SAN FRANCISCO, CA / ACCESSWIRE / May 12, 2021 /
Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the Company ) has submitted its initial application to the NASDAQ to begin the process of moving the listing from the Pink Sheets to the Capital Markets Tier of the NASDAQ Exchange. The Company, its Board, advisors and management team are going to devote resources to accomplish this as swiftly as possible. We are delighted to have submitted the initial application and will work through the process utilizing all resources to our disposal. ....

San Francisco , United States , Oncology Pharma Inc , Oncology Pharma , Pink Sheets , Capital Markets Tier , Advisory Board , Sansome Street , சான் பிரான்சிஸ்கோ , ஒன்றுபட்டது மாநிலங்களில் , புற்றுநோயியல் பார்மா இன்க் , புற்றுநோயியல் பார்மா , இளஞ்சிவப்பு தாள்கள் ,

Oncology Pharma Inc.: Oncology Pharma Enters into License Agreement for Small Molecules Intellectual Property for the Treatment of Colon Cancer

(1)
SAN FRANCISCO, CA / ACCESSWIRE / May 7, 2021 /
Oncology Pharma Inc. (OTC PINK:ONPH) ONPH has entered into a licensing agreement with Regen BioPharma, Inc. for a technology utilizing small molecules to activate immune checkpoints for the treatment of colon cancer. The program entails identifying small molecules that inhibit the NR2F6 nuclear receptor. The NR2F6 nuclear receptor has been identified as a potentially critical immune cell inhibitor (an immune checkpoint) and cancer stem cell differentiator. Regen BioPharma believes that by inhibiting the NR2F6 nuclear receptor, one can unleash the cancer-killing potential of a patient s own immune system. Regen is also engaged in the identification of small molecules which activate the NR2F6 nuclear receptor that can be utilized to develop small molecule therapies for autoimmune disorders. ....

San Francisco , United States , Kostenloser Wertpapierhandel , Regen Biopharma , Regen Biopharma Inc , Oncology Pharma Inc , Oncology Pharma , Advisory Board , Sansome Street , சான் பிரான்சிஸ்கோ , ஒன்றுபட்டது மாநிலங்களில் , புற்றுநோயியல் பார்மா இன்க் , புற்றுநோயியல் பார்மா ,

Oncology Pharma Enters into License Agreement for Small Molecules Intellectual Property for the Treatment of Colon Cancer

Oncology Pharma Enters into License Agreement for Small Molecules Intellectual Property for the Treatment of Colon Cancer
ACCESSWIRE
SAN FRANCISCO, CA / ACCESSWIRE / May 7, 2021 /
Oncology Pharma Inc. (OTC PINK:ONPH) ONPH has entered into a licensing agreement with Regen BioPharma, Inc. for a technology utilizing small molecules to activate immune checkpoints for the treatment of colon cancer. The program entails identifying small molecules that inhibit the NR2F6 nuclear receptor. The NR2F6 nuclear receptor has been identified as a potentially critical immune cell inhibitor (an immune checkpoint) and cancer stem cell differentiator. Regen BioPharma believes that by inhibiting the NR2F6 nuclear receptor, one can unleash the cancer-killing potential of a patient s own immune system. Regen is also engaged in the identification of small molecules which activate the NR2F6 nuclear receptor that can be utilized to develop small molecule therapies for autoimmune disorders. ....

San Francisco , United States , Regen Biopharma , Regen Biopharma Inc , Oncology Pharma Inc , Oncology Pharma , Advisory Board , Sansome Street , சான் பிரான்சிஸ்கோ , ஒன்றுபட்டது மாநிலங்களில் , புற்றுநோயியல் பார்மா இன்க் , புற்றுநோயியல் பார்மா ,